To United States of America found out that interferon cannot be applied at treatment of Koronavirus

Research National institutes an allergy and infectious diseases of United States of America showed that Rekombinantny interferon beta-1 not only has no effect at treatment Koronavirus, but also leads to complications at those patients who are on IVL. 969 people who passed treatment from Koronavirus in 63 hospitals the countries of United States of America, Mexico, Japan, Singapore and South Korea took part in research. Them divided into two groups: one was given Rekombinantny interferon beta-1 in combination with an anti-virus preparation remdeseviry, and another – only remdesevir. It became clear that a condition of the patients accepting a combination...